Dimensional Fund Advisors
NEO icon

Dimensional Fund Advisors’s NeoGenomics NEO Stock Holding History

Dimensional Fund Advisors’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.8M Buy
2,674,335
+225,588
+9% +$2.37M ﹤0.01% 1976
2025
Q4 		$28.8M Sell
2,448,747
-1,379,066
-36% -$14.9M 0.01% 1795
2025
Q3 		$29.6M Sell
3,827,813
-465,844
-11% -$3.26M 0.01% 1804
2025
Q2 		$31.4M Buy
4,293,657
+448,528
+12% +$3.62M 0.01% 1761
2025
Q1 		$36.5M Buy
3,845,129
+408,271
+12% +$5.1M 0.01% 1634
2024
Q4 		$56.6M Buy
3,436,858
+78,211
+2% +$1.21M 0.01% 1445
2024
Q3 		$49.5M Buy
3,358,647
+34,023
+1% +$532K 0.01% 1519
2024
Q2 		$46.1M Buy
3,324,624
+217,687
+7% +$3.09M 0.01% 1517
2024
Q1 		$48.8M Buy
3,106,937
+100,414
+3% +$1.55M 0.01% 1468
2023
Q4 		$48.6M Buy
3,006,523
+18,603
+0.6% +$304K 0.01% 1468
2023
Q3 		$36.8M Buy
2,987,920
+7,546
+0.3% +$112K 0.01% 1544
2023
Q2 		$47.9M Buy
2,980,374
+287,767
+11% +$4.74M 0.02% 1385
2023
Q1 		$46.9M Buy
2,692,607
+902,024
+50% +$12.8M 0.02% 1374
2022
Q4 		$16.5K Buy
1,790,583
+816,712
+84% +$7.61M ﹤0.01% 1958
2022
Q3 		$8.38M Sell
973,871
-250,303
-20% -$2.49M ﹤0.01% 2233
2022
Q2 		$9.98M Sell
1,224,174
-191,804
-14% -$1.83M ﹤0.01% 2195
2022
Q1 		$17.2M Sell
1,415,978
-119,878
-8% -$2.52M 0.01% 2041
2021
Q4 		$52.4M Buy
1,535,856
+154,691
+11% +$6.06M 0.02% 1376
2021
Q3 		$66.6M Buy
1,381,165
+314,094
+29% +$14.5M 0.02% 1175
2021
Q2 		$48.2M Buy
1,067,071
+146,755
+16% +$6.5M 0.02% 1483
2021
Q1 		$44.4M Sell
920,316
-273,883
-23% -$14.3M 0.01% 1540
2020
Q4 		$64.3M Sell
1,194,199
-113,918
-9% -$5.15M 0.02% 1149
2020
Q3 		$48.3M Sell
1,308,117
-55,243
-4% -$2.05M 0.02% 1235
2020
Q2 		$42.2M Sell
1,363,360
-207,318
-13% -$5.75M 0.02% 1352
2020
Q1 		$43.4M Buy
1,570,678
+106,045
+7% +$3.18M 0.02% 1145
2019
Q4 		$42.8M Buy
1,464,633
+5,147
+0.4% +$123K 0.02% 1568
2019
Q3 		$27.9M Buy
1,459,486
+55,921
+4% +$1.31M 0.01% 1825
2019
Q2 		$30.8M Buy
1,403,565
+141,408
+11% +$3.1M 0.01% 1800
2019
Q1 		$25.8M Buy
1,262,157
+123,916
+11% +$2.15M 0.01% 1912
2018
Q4 		$14.4M Buy
1,138,241
+172,451
+18% +$2.57M 0.01% 2168
2018
Q3 		$14.8M Buy
965,790
+212,937
+28% +$2.94M 0.01% 2265
2018
Q2 		$9.87M Buy
752,853
+165,451
+28% +$1.82M ﹤0.01% 2425
2018
Q1 		$4.79M Sell
587,402
-7,481
-1% -$60.6K ﹤0.01% 2644
2017
Q4 		$5.27M Sell
594,883
-7,923
-1% -$73.1K ﹤0.01% 2599
2017
Q3 		$6.71M Sell
602,806
-46,254
-7% -$450K ﹤0.01% 2508
2017
Q2 		$5.82M Buy
649,060
+244,434
+60% +$1.94M ﹤0.01% 2530
2017
Q1 		$3.19M Buy
404,626
+256,282
+173% +$2.09M ﹤0.01% 2720
2016
Q4 		$1.27M Buy
+148,344
New +$1.27M ﹤0.01% 2920

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Dimensional Fund Advisors's NEO Position: Q1 2026 in Review

Dimensional Fund Advisors increased its NeoGenomics (NEO) stake by 9.2% in Q1 2026, buying an estimated $2.37M and bringing the position to 2,674,335 shares worth $19.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1976.

Dimensional Fund Advisors first reported a position in NEO in Q4 2016 and has held it in 38 quarters since. The position peaked at $66.6M in Q3 2021. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Dimensional Fund Advisors held 2,674,335 shares of NeoGenomics worth $19.8M as of Q1 2026.
  • Dimensional Fund Advisors bought 225,588 NeoGenomics shares in Q1 2026, an estimated $2.37M.
  • NeoGenomics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #1976 holding.
  • Dimensional Fund Advisors first reported a position in NeoGenomics in Q4 2016 and has held it in 38 quarters since.
  • Dimensional Fund Advisors's NeoGenomics position peaked at $66.6M in Q3 2021.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.